Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
2.060
+0.110 (5.64%)
Mar 20, 2026, 4:00 PM EDT - Market closed
APUS Market Cap
APUS has a market cap or net worth of $25.91 million as of March 20, 2026.
Market Cap
25.91M
Enterprise Value
n/a
1-Year Change
n/a
Ranking
Category
Stock Price
$2.06
Market Cap Chart
Since the IPO on December 9, 2025, APUS's market cap has decreased from $26.79M to $25.91M, a decrease of -3.29%. That is a compound annual growth rate of -11.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 25.91M | 25.61% |
| Dec 31, 2025 | 20.62M | -23.00% |
| Dec 9, 2025 | 26.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Incannex Healthcare | 42.86M |
| Cumberland Pharmaceuticals | 42.33M |
| SCYNEXIS | 41.64M |
| Rockwell Medical | 41.38M |
| Talphera | 38.82M |
| InterCure | 36.49M |
| Zhengye Biotechnology Holding | 33.65M |
| BioXcel Therapeutics | 33.02M |